TY - JOUR
T1 - Chemical synthesis of benzamide adenine dinucleotide
T2 - Inhibition of inosine monophosphate dehydrogenase (types I and II)
AU - Zatorski, Andrzej
AU - Watanabe, Kyoichi A.
AU - Carr, Stephen F.
AU - Goldstein, Barry M.
AU - Pankiewicz, Krzysztof W.
PY - 1996/6/7
Y1 - 1996/6/7
N2 - Treatment of 3-(2,3-O-isopropylidene-β-D-ribofuranosyl)benzamide (6) with POCl3 in (EtO)3-PO afforded only little phosphorylation product (8, 5%), but the major product was 5'-chlorobenzamide riboside (7, 85%). Reaction of 6 with 2-cyanoethyl N,N-diisopropylchlorophosphoramidite followed by 2- cyanoethanol/tetrazole treatment and oxidation with tert-butyl peroxide gave a 1:1 mixture of the desired 5'-O-bis(2-cyanoethyl) phosphate 9 and the chloro derivative 7. This mixture was treated with methanolic ammonia and partitioned between CHCl3 and water. The 2',3'-O-isopropylidenebenzamide mononucleotide (8) was obtained in 21.2% overall yield from the aqueous layer. Compound 8 was then converted into the corresponding imidazolide 11b which, upon coupling with 2',3'-O-acetonide of AMP, afforded the acetonide of benzamide adenine dinucleotide (15) in 94% yield together with small amounts of symmetrical pyrophosphates P1,P2-bis(2',3'-O-isopropylideneadenosin-5'- yl)pyrophosphate (13, 3%) and P1,P2-bis(2',3',O-isopropylidene-3- (carbamoylphenyl)-5'-ribosyl)pyrophosphate (14, 2%). Deprotection of 15 with Dowex 50/H+ in water afforded the desired benzamide adenine dinucleotide (BAD) in 93% yield. BAD inhibits inosine monophosphate dehydrogenase type I (IC50 = 0.78 μM) and type II (IC50 = 0.88 μM) with same degree of potency.
AB - Treatment of 3-(2,3-O-isopropylidene-β-D-ribofuranosyl)benzamide (6) with POCl3 in (EtO)3-PO afforded only little phosphorylation product (8, 5%), but the major product was 5'-chlorobenzamide riboside (7, 85%). Reaction of 6 with 2-cyanoethyl N,N-diisopropylchlorophosphoramidite followed by 2- cyanoethanol/tetrazole treatment and oxidation with tert-butyl peroxide gave a 1:1 mixture of the desired 5'-O-bis(2-cyanoethyl) phosphate 9 and the chloro derivative 7. This mixture was treated with methanolic ammonia and partitioned between CHCl3 and water. The 2',3'-O-isopropylidenebenzamide mononucleotide (8) was obtained in 21.2% overall yield from the aqueous layer. Compound 8 was then converted into the corresponding imidazolide 11b which, upon coupling with 2',3'-O-acetonide of AMP, afforded the acetonide of benzamide adenine dinucleotide (15) in 94% yield together with small amounts of symmetrical pyrophosphates P1,P2-bis(2',3'-O-isopropylideneadenosin-5'- yl)pyrophosphate (13, 3%) and P1,P2-bis(2',3',O-isopropylidene-3- (carbamoylphenyl)-5'-ribosyl)pyrophosphate (14, 2%). Deprotection of 15 with Dowex 50/H+ in water afforded the desired benzamide adenine dinucleotide (BAD) in 93% yield. BAD inhibits inosine monophosphate dehydrogenase type I (IC50 = 0.78 μM) and type II (IC50 = 0.88 μM) with same degree of potency.
UR - http://www.scopus.com/inward/record.url?scp=0029894336&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029894336&partnerID=8YFLogxK
U2 - 10.1021/jm9601415
DO - 10.1021/jm9601415
M3 - Article
C2 - 8691436
AN - SCOPUS:0029894336
SN - 0022-2623
VL - 39
SP - 2422
EP - 2426
JO - Journal of medicinal chemistry
JF - Journal of medicinal chemistry
IS - 12
ER -